Judge Advances Lilly Suit Over Online Platforms’ Mounjaro Copies

A federal judge ruled Eli Lilly & Co. can proceed with its challenge against two telehealth platforms promoting copycat versions of its obesity and diabetes treatments, finding the drugmaker sufficiently demonstrated that it suffers economic harm from their actions.

“Eli Lilly has adequately alleged that Fella sells those products to the same consumers who purchase Eli Lilly’s medicines,” Judge Haywood S. Gilliam Jr. for the US District Court for the Northern District of California said in an order filed Thursday. “Eli Lilly has also adequately alleged both economic and reputational injury flowing directly from Fella’s alleged deception of consumers through ...